Gender effect on metformin and sitagliptin [Regulatives / Guidelines]

posted by khageswara Rao – India, 2022-03-01 08:26 (811 d 02:12 ago) – Posting: # 22816
Views: 1,450

Dear All,

As per updated guidelines

If a drug product is intended for use in both sexes, the applicant should include similar proportions of males and females in the study or provide a justification supporting the use of a single-sex population.

for metformin and Sitagliptin we have enrolled only male subjects so please provide the justification on the same of gender effect. with references.

Your quick response will much helpful

Thanks in advance.

Complete thread:

UA Flag
Activity
 Admin contact
23,033 posts in 4,835 threads, 1,643 registered users;
45 visitors (0 registered, 45 guests [including 10 identified bots]).
Forum time: 11:39 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5